1.
Leelo Al-Obaidy AK, A. Kareem H, Jabbar Hasan Y. Impact of Thyroid Hormone Receptor alpha Expression and PD-L1 on Progression-Free Survival of NSCLC Patients Treated with Pembrolizumab Immunotherapy. J Neonatal Surg [Internet]. 2025 Mar. 5 [cited 2026 Feb. 7];14(4S):1217-31. Available from: https://jneonatalsurg.com/index.php/jns/article/view/1937